Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_provenance.
• NP914042.RAQmN_TsdU7dLW7TPUuQA-Lk7P_qEa5znQpUUOU7n_SH4130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914042.RAQmN_TsdU7dLW7TPUuQA-Lk7P_qEa5znQpUUOU7n_SH4130_provenance.
• NP606002.RAQXi01hLVewqS1SYB0vSTxmgrc5BqS5t696ikRhrT9jo130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606002.RAQXi01hLVewqS1SYB0vSTxmgrc5BqS5t696ikRhrT9jo130_provenance.
• NP606149.RAcOO3ucGR0qJnW5KiJeL1TpCwcM2PLNwSbqyAwfmsEgA130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606149.RAcOO3ucGR0qJnW5KiJeL1TpCwcM2PLNwSbqyAwfmsEgA130_provenance.
• NP781580.RAh7lfmjhatu0ZTCBv_HFSMIGyldMtD5dHA7zNAHVKZ5A130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781580.RAh7lfmjhatu0ZTCBv_HFSMIGyldMtD5dHA7zNAHVKZ5A130_provenance.
• NP349696.RACmyA-1nCTiq0nlSu-4bYTqIQib-AFRFZHuK5s8av9aM130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349696.RACmyA-1nCTiq0nlSu-4bYTqIQib-AFRFZHuK5s8av9aM130_provenance.
• NP349697.RACIUxUsP1UB5McAkTIFmivEWcB6XJYuPpcM7i2rcX5yo130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349697.RACIUxUsP1UB5McAkTIFmivEWcB6XJYuPpcM7i2rcX5yo130_provenance.
• NP349704.RAASsbsjugJgp-GCs965vrmeLzx7558B1uqzlaxqxs_KI130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349704.RAASsbsjugJgp-GCs965vrmeLzx7558B1uqzlaxqxs_KI130_provenance.
• NP349703.RAQBPKAK7BvziqUkMCjsVxwJREkB7rjUujgv4G3CNG3Ss130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349703.RAQBPKAK7BvziqUkMCjsVxwJREkB7rjUujgv4G3CNG3Ss130_provenance.
• NP349706.RAf3w2LwF3gvMjBdzhuqZS9tQjel9GGPsNYQ1bmuR1zMw130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349706.RAf3w2LwF3gvMjBdzhuqZS9tQjel9GGPsNYQ1bmuR1zMw130_provenance.
• NP349707.RAe-dRRFD1uFQfzORPrlmncnXH7oV-4n_QeSsZKYbV4S8130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349707.RAe-dRRFD1uFQfzORPrlmncnXH7oV-4n_QeSsZKYbV4S8130_provenance.
• NP873209.RAgSCJQdZ0psB4hBQPhK0RPjBK3PZUVe79VV22frOFJiA130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873209.RAgSCJQdZ0psB4hBQPhK0RPjBK3PZUVe79VV22frOFJiA130_provenance.
• NP349700.RAjjea35h6XEz_xdaX_OwvUjsWSkWxPaIalOICB3pVe8I130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349700.RAjjea35h6XEz_xdaX_OwvUjsWSkWxPaIalOICB3pVe8I130_provenance.
• NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_provenance.
• NP349708.RAMBOq8A9yaXKsWvROlgKLfnGDXFAbBmbcGrWN4rzlR8U130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349708.RAMBOq8A9yaXKsWvROlgKLfnGDXFAbBmbcGrWN4rzlR8U130_provenance.
• NP781446.RAMx8HqdUsn_UNES4jUKOEiAPJqhCZOG3ZVaSwHrFXM6E130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781446.RAMx8HqdUsn_UNES4jUKOEiAPJqhCZOG3ZVaSwHrFXM6E130_provenance.
• NP873312.RAJ1ui6YhocONIAIJlEbC7iaV9y2SNXXkTonatDrnNU5I130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873312.RAJ1ui6YhocONIAIJlEbC7iaV9y2SNXXkTonatDrnNU5I130_provenance.
• NP978669.RAGS3lvjsaZYdXz7Y1ZpFK1267SI1qYRJfSRFEluBrH-c130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978669.RAGS3lvjsaZYdXz7Y1ZpFK1267SI1qYRJfSRFEluBrH-c130_provenance.
• NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_provenance.
• NP914197.RAzTeogozEF6ubRZYqjFpe53KMnEgNWKkYYp7RiEuOUGE130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914197.RAzTeogozEF6ubRZYqjFpe53KMnEgNWKkYYp7RiEuOUGE130_provenance.
• NP349699.RA-yGPpRY8dHKza3uNMn7snSqVFNUMfb3dcyduDJaQxSc130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349699.RA-yGPpRY8dHKza3uNMn7snSqVFNUMfb3dcyduDJaQxSc130_provenance.
• NP349701.RA9-5DbdnP9cHSuElLia_wHndriHkYHenvOgWV3MI6Orc130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349701.RA9-5DbdnP9cHSuElLia_wHndriHkYHenvOgWV3MI6Orc130_provenance.
• NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349705.RA2fNGn0ryYYKxngL-EVdk41Ht_918io_QXL2JnOqFnlQ130_provenance.